GO:0000176 nuclear exosome (RNase complex): Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000176 describes the nuclear exosome (RNase complex), a conserved 3-prime to 5-prime exoribonuclease and endoribonuclease machine that degrades or processes aberrant and regulatory nuclear RNAs.
• The catalytic core is built from EXOSC1-EXOSC9 subunits, with EXOSC10 providing the main nuclear hydrolytic activity and DIS3 contributing both exonuclease and endonuclease functions.
• Substrate specificity is largely dictated by cofactors: the NEXT complex (ZCCHC8, RBM7, MTREX) targets short, unstructured, newly transcribed RNAs, while the TRAMP-like complex and MTR4 adapt the exosome to longer or structured targets.
• The nuclear exosome is essential for RNA surveillance, preventing nuclear export and translation of aberrant transcripts, and for 3-prime processing of stable RNAs such as ribosomal, small nuclear and small nucleolar RNAs.
• Dysregulation of nuclear exosome components and cofactors is linked to cancer, hematopoietic stem cell failure, genomic instability and R-loop accumulation.
• CRISPR knockout, point-mutation, knock-in and overexpression models, combined with RNA-seq, Ribo-seq, proteomics and imaging, are the core tools for dissecting nuclear exosome function.
Description
The nuclear exosome (RNase complex), annotated as GO:0000176, is a multisubunit ribonuclease complex that carries out 3-prime to 5-prime processive and distributive hydrolytic exoribonuclease activity and endoribonuclease activity, generating 5-prime-phosphomonoesters. It is restricted to processing linear and circular single-stranded RNAs, and structured 3-prime ends may require unwinding or pre-processing by cofactors before entering the complex. This complex is a central node of nuclear RNA surveillance and processing, preventing nuclear export and/or translation of aberrant RNAs. For researchers, GO:0000176 matters because it connects RNA metabolism to gene regulation, genome stability and disease. The nuclear exosome degrades or trims a wide range of substrates, including cryptic unstable transcripts, aberrant splicing products, and normal precursors of ribosomal, small nuclear and small nucleolar RNAs. Its activity is directed by cofactors such as the NEXT complex, which recognizes short, unstructured RNA targets and delivers them to the exosome catalytic core. Recent structural and functional studies have clarified how the NEXT complex guides RNA substrates to the exosome and how oncoproteins such as MYCN and MYC interface with this machinery. These findings make the nuclear exosome a tractable target for CRISPR-based functional genomics, especially in cancer and stem cell biology.
nuclear exosome (RNase complex) At A Glance
| GO ID | GO:0000176 |
|---|---|
| GO term | nuclear exosome (RNase complex) |
| Ontology | cellular_component |
| Synonym | eukaryotic exosome multienzyme ribonuclease complex; nuclear exosome multienzyme ribonuclease complex; nuclear exosome (ribonuclease complex) |
| Major function | 3-prime to 5-prime exoribonuclease and endoribonuclease activity on single-stranded RNAs, producing 5-prime-phosphomonoesters; RNA surveillance and processing |
| Substrate range | Linear and circular single-stranded RNAs; structured 3-prime ends may require cofactor-assisted unwinding or pre-processing |
| Cellular role | Prevents nuclear export and/or translation of aberrant RNAs; participates in processing and degradation of many nuclear RNA species |
| Key cofactors | NEXT complex (ZCCHC8, RBM7, MTREX), TRAMP-like complex, MTR4 |
| Catalytic subunits | EXOSC10, DIS3, and the EXOSC1-EXOSC9 core |
What Is GO:0000176?
GO:0000176, nuclear exosome (RNase complex), is a cellular component ontology term describing a ribonuclease complex with 3-prime to 5-prime processive and distributive hydrolytic exoribonuclease activity and endoribonuclease activity that produces 5-prime-phosphomonoesters. It participates in many cellular RNA processing and degradation events, preventing nuclear export and/or translation of aberrant RNAs. The complex is restricted to processing linear and circular single-stranded RNAs; RNAs with complex secondary structures may need to be unwound or pre-processed by cofactors before entering the complex, especially if the 3-prime end is structured.
Why Is nuclear exosome (RNase complex) Important in Cell Biology?
The nuclear exosome (RNase complex) is important because it safeguards the nuclear transcriptome by degrading aberrant, cryptic and misprocessed RNAs before they can be exported or translated. It also performs essential 3-prime processing of stable non-coding RNAs, including ribosomal, small nuclear and small nucleolar RNAs. Because its substrate selection depends on cofactors such as the NEXT complex, the exosome sits at the interface of transcription, splicing and RNA decay. Perturbations in this system have been linked to cancer, hematopoietic stem cell failure, R-loop accumulation and genomic instability, making it a high-value target for functional genomics and therapeutic hypothesis testing.
• Prevents nuclear export and translation of aberrant RNAs, protecting the cell from toxic or dominant-negative protein products.
• Processes and matures stable non-coding RNAs, including ribosomal, small nuclear and small nucleolar RNAs.
• Coordinates with splicing and transcription to resolve R-loops and maintain genomic integrity.
• Controls the half-life of regulatory and cryptic transcripts, thereby influencing gene expression programs.
• Is targeted or co-opted by oncoproteins such as MYCN and MYC, linking it to cancer cell growth and immune signaling.
• Supports hematopoietic stem cell self-renewal and genomic stability, with implications for bone marrow failure and leukemia.
• Provides a mechanistic entry point for understanding RNA surveillance defects in developmental and neurological disease.
• Offers a rich set of cofactor dependencies (NEXT, TRAMP-like, MTR4) that can be dissected by CRISPR screening.
• Serves as a model system for studying how structured versus unstructured RNA ends are recognized and processed.
• Enables translational research on RNA-targeting therapeutics and biomarkers of RNA processing dysfunction.
Core Biology of GO:0000176 nuclear exosome (RNase complex)
Substrate recognition and targeting
In simple terms: The exosome does not choose its targets alone; helper proteins mark which RNAs should be degraded or trimmed.
The nuclear exosome is directed to substrates by cofactors that recognize features such as short, unstructured 3-prime ends or specific sequence elements. The NEXT complex, composed of ZCCHC8, RBM7 and the helicase MTREX, binds short, newly transcribed RNAs and guides them to the exosome catalytic core. Structural studies show how NEXT positions RNA substrates for handoff to the exosome, ensuring that only appropriate RNAs enter the degradation channel. This targeting step is critical because the exosome itself has limited intrinsic specificity and relies on cofactors to avoid degrading stable transcripts.
Catalytic degradation and processing
In simple terms: Once an RNA is delivered, the exosome chews it from the 3-prime end, either destroying it completely or trimming it to a mature form.
The catalytic core of the nuclear exosome contains EXOSC10, a distributive 3-prime to 5-prime exoribonuclease, and DIS3, which provides both processive exoribonuclease and endoribonuclease activities. These enzymes produce 5-prime-phosphomonoesters as they hydrolyze RNA. The complex can degrade linear and circular single-stranded RNAs, but structured 3-prime ends may require unwinding or pre-processing by cofactors such as MTREX before entering the catalytic channel. This dual capability allows the exosome to both destroy aberrant transcripts and trim normal precursors to their mature lengths.
RNA surveillance and quality control
In simple terms: The exosome acts as a quality-control inspector that destroys faulty RNAs before they can cause harm.
A major function of the nuclear exosome is to prevent nuclear export and/or translation of aberrant RNAs, including cryptic unstable transcripts, mis-spliced mRNAs and defective ribosomal RNA precursors. The spliceosome-exosome pathway is evolutionarily conserved and couples splicing to nuclear mRNA surveillance, ensuring that intron-containing or improperly processed transcripts are retained and degraded in the nucleus. This surveillance function protects the cell from dominant-negative or toxic protein products and maintains the fidelity of gene expression.
Integration with transcription and R-loop biology
In simple terms: The exosome also helps clean up RNA that gets tangled with DNA during transcription, preventing genome instability.
Nuclear exosome activity is functionally connected to transcription and R-loop metabolism. Loss of the NEXT complex component ZCCHC8 leads to R-loop accumulation and impaired hematopoietic stem cell self-renewal, indicating that exosome-mediated RNA processing safeguards genomic integrity. MYC binding to nascent RNA suppresses innate immune signaling by preventing R-loop-derived RNA-DNA hybrids, a process that intersects with nuclear RNA decay pathways. These findings place the exosome in a broader network that coordinates RNA processing with genome stability and immune surveillance.
Cofactor diversity and regulation
In simple terms: Different helper complexes adapt the same exosome to different jobs in the nucleus.
The nuclear exosome interacts with multiple cofactors, including the NEXT complex, TRAMP-like complexes and the helicase MTR4, which collectively determine substrate specificity and activity. The Microprocessor complex has been functionally connected to a variant NEXT complex, expanding the range of RNA substrates that can be targeted. Oncoproteins such as MYCN can act as RNA-binding accessory factors of the nuclear exosome targeting complex, linking exosome regulation to cancer gene expression programs. Together, these cofactors allow the exosome to participate in diverse nuclear RNA processing and degradation events.
Key Genes Involved in GO:0000176 nuclear exosome (RNase complex)
The following genes and proteins represent the core catalytic subunits, cofactors and regulatory interactors of the nuclear exosome (RNase complex) that are most relevant to functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EXOSC1 | Core exosome subunit | Structural and functional studies of the exosome barrel |
| EXOSC2 | Core exosome subunit | RNA processing and surveillance assays |
| EXOSC3 | Core exosome subunit | Links exosome function to neurological disease models |
| EXOSC4 | Core exosome subunit | Core scaffold for catalytic subunits |
| EXOSC5 | Core exosome subunit | RNA binding and degradation studies |
| EXOSC6 | Core exosome subunit | Structural studies of the exosome complex |
| EXOSC7 | Core exosome subunit | Core scaffold and cofactor interaction |
| EXOSC8 | Core exosome subunit | RNA surveillance and processing |
| EXOSC9 | Core exosome subunit | Core exosome assembly and stability |
| EXOSC10 | Catalytic 3-prime to 5-prime exoribonuclease | Main nuclear hydrolytic activity; target for KO and point-mutation studies |
| DIS3 | Catalytic exoribonuclease and endoribonuclease | Dual catalytic activities; cancer-related mutations |
| ZCCHC8 | NEXT complex subunit | Substrate targeting; R-loop and stem cell studies |
| RBM7 | NEXT complex RNA-binding subunit | Recognition of short unstructured RNAs |
| MTREX | Helicase (MTR4) in NEXT/TRAMP-like complexes | Unwinding structured RNA ends for exosome entry |
| MYCN | RNA-binding accessory factor of NEXT | Oncoprotein-exosome crosstalk in cancer |
| MYC | Transcription factor linked to R-loop suppression | Innate immune signaling and RNA-DNA hybrid regulation |
| Microprocessor components | Variant NEXT complex connection | Functional link between Microprocessor and exosome targeting |
How Is nuclear exosome (RNase complex) Regulated?
The nuclear exosome is regulated at multiple levels. Substrate selection is controlled by cofactors such as the NEXT complex, which recognizes short, unstructured RNAs and delivers them to the exosome. The helicase MTREX (MTR4) is required to unwind structured 3-prime ends before they can enter the catalytic channel. Oncoproteins such as MYCN can act as RNA-binding accessory factors of the NEXT complex, suggesting that exosome targeting is modulated in cancer cells. MYC binding to nascent RNA suppresses innate immune signaling by preventing R-loop-derived RNA-DNA hybrids, indirectly influencing the RNA substrates available for nuclear surveillance. In addition, the Microprocessor complex has been functionally connected to a variant NEXT complex, indicating that exosome targeting can be rewired by alternative cofactor assemblies. Loss of ZCCHC8 leads to R-loop accumulation and impaired hematopoietic stem cell self-renewal, showing that exosome regulation is critical for stem cell and genomic integrity.
nuclear exosome (RNase complex) and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYCN | Oncoprotein-driven cancer; RNA-binding accessory factor of NEXT | MYCN overexpression and knockout in neuroblastoma cell lines |
| ZCCHC8 | Hematopoietic stem cell failure; R-loop accumulation; genomic instability | ZCCHC8 knockout in hematopoietic stem cells and cell lines |
| MYC | Cancer; innate immune signaling; R-loop-derived RNA-DNA hybrids | MYC point-mutation and knockout models with RNA-seq and R-loop assays |
| EXOSC10 | RNA processing disorders; cancer-related RNA surveillance defects | EXOSC10 knockout and catalytic-dead point mutants |
| DIS3 | Cancer-associated mutations; RNA processing defects | DIS3 knockout and point-mutation knock-in models |
Cancer and oncoprotein crosstalk
Nuclear exosome components and cofactors are linked to cancer through their interactions with oncoproteins and their role in RNA surveillance. MYCN acts as an RNA-binding accessory factor of the nuclear exosome targeting complex, connecting exosome function to MYCN-driven gene expression programs. MYC binding to nascent RNA suppresses innate immune signaling by preventing R-loop-derived RNA-DNA hybrids, a process that intersects with nuclear RNA decay and genome stability. These findings suggest that cancer cells may depend on nuclear exosome activity to manage oncogenic RNA and R-loop burdens.
Hematopoietic stem cell failure and genomic instability
The nuclear exosome targeting complex safeguards hematopoietic stem cell self-renewal and genomic integrity through resolving R loops. Loss of ZCCHC8, a NEXT complex subunit, leads to R-loop accumulation and impaired stem cell function, providing a mechanistic link between exosome-mediated RNA processing and bone marrow failure or leukemia predisposition. This work highlights the exosome as a guardian of genome stability in stem cell compartments.
RNA processing disorders and neurological disease
Core exosome subunits such as EXOSC3 and EXOSC8 have been associated with neurological and developmental phenotypes in model systems, reflecting the essential role of the exosome in processing stable non-coding RNAs and surveillance of aberrant transcripts. Defects in nuclear RNA surveillance can lead to accumulation of cryptic or misprocessed RNAs, which may contribute to cellular stress and disease. The spliceosome-exosome pathway is evolutionarily conserved, underscoring the importance of this machinery for normal development.
Innate immune signaling and R-loop biology
Nuclear exosome activity intersects with innate immune signaling through R-loop metabolism. MYC binding to nascent RNA suppresses innate immune signaling by preventing R-loop-derived RNA-DNA hybrids, a function that depends on proper nuclear RNA handling. Loss of exosome targeting factors leads to R-loop accumulation, which can trigger DNA damage responses and immune activation. These connections position the nuclear exosome as a modulator of inflammation and genome surveillance.
From nuclear exosome (RNase complex)-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What happens when a core exosome subunit is lost? | CRISPR knockout of EXOSC1-EXOSC9 or EXOSC10 in cell lines |
| How does catalytic activity contribute to RNA surveillance? | Point-mutation knock-in of catalytic-dead EXOSC10 or DIS3 |
| How does NEXT complex targeting affect substrate selection? | Knockout or tagged knock-in of ZCCHC8, RBM7 or MTREX |
| Does oncoprotein binding modulate exosome function? | Overexpression or knockout of MYCN with RNA-seq and proteomics |
| How does exosome loss affect R-loops and genome stability? | ZCCHC8 knockout in hematopoietic stem cells with R-loop assays |
| How does MYC-RNA interaction affect innate immune signaling? | MYC point-mutation and overexpression models with RNA-DNA hybrid detection |
How to Study the nuclear exosome (RNase complex) Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Accumulation of aberrant or misprocessed RNAs | Defining exosome substrate repertoire |
| Ribo-seq | Translation of aberrant RNAs | Testing whether exosome loss leads to nuclear export and translation |
| Structural biology (cryo-EM) | Architecture of exosome-cofactor complexes | Understanding NEXT-mediated substrate handoff |
| Biochemical nuclease assays | Exoribonuclease and endoribonuclease activity | Measuring catalytic activity of EXOSC10 and DIS3 |
| Affinity proteomics | Exosome interactome and cofactor composition | Identifying NEXT and TRAMP-like components |
| R-loop detection assays | RNA-DNA hybrid accumulation | Linking exosome loss to genome instability |
| CRISPR knockout screens | Fitness and RNA processing phenotypes | Identifying exosome dependencies in cancer cells |
| Imaging (RNA FISH) | Nuclear RNA localization | Visualizing surveillance defects |
RNA-seq and transcriptome-wide surveillance assays
RNA-seq is widely used to identify RNAs that accumulate upon loss of nuclear exosome subunits or cofactors, revealing cryptic unstable transcripts, misprocessed mRNAs and stable RNA precursors. Comparing wild-type and knockout cells can define the substrate repertoire of the exosome and its cofactors. These approaches are often combined with splicing-sensitive assays to detect surveillance defects.
Structural and biochemical reconstitution
Structural studies of the human nuclear exosome targeting (NEXT) complex have revealed how RNA substrates are recognized and guided to the exosome catalytic core. Biochemical reconstitution with purified subunits and cofactors allows measurement of exoribonuclease and endoribonuclease activities on defined RNA substrates. These methods are essential for understanding how structured 3-prime ends are unwound or pre-processed before entering the complex.
Proteomics and interactome mapping
Affinity purification and mass spectrometry can identify exosome-associated proteins and cofactors, including NEXT components and helicases. Proteomic approaches have been used to show that MYCN interacts with the nuclear exosome targeting complex, expanding the known regulatory network. These methods help define how cofactor composition changes across cell types and conditions.
Imaging and R-loop detection
Imaging-based assays, including RNA fluorescence in situ hybridization and R-loop detection, can visualize the accumulation of nuclear RNAs and RNA-DNA hybrids upon exosome perturbation. These methods link exosome dysfunction to genome instability and innate immune signaling. Combining imaging with CRISPR knockouts provides spatial and mechanistic insight into nuclear RNA surveillance.
How CRISPR Can Be Used to Study GO:0000176 nuclear exosome (RNase complex)
Knockout
CRISPR knockout of nuclear exosome subunits such as EXOSC10, DIS3 or core EXOSC genes can reveal their essential roles in RNA surveillance and processing. Knockout of cofactors like ZCCHC8 has been used to demonstrate R-loop accumulation and impaired hematopoietic stem cell self-renewal. These models are foundational for defining which RNAs depend on the exosome for their processing or degradation.
Point Mutation
Point-mutation knock-in of catalytic residues in EXOSC10 or DIS3 allows separation of catalytic activity from scaffold functions. Such models are valuable for testing whether exoribonuclease or endoribonuclease activity is required for specific surveillance pathways. They also help distinguish direct catalytic effects from loss of protein-protein interactions.
Knock-in
Tagged knock-in of exosome subunits or cofactors, such as ZCCHC8 or MTREX, enables affinity purification and imaging of endogenous complexes. Knock-in of disease-associated mutations can model how specific variants affect RNA processing and genome stability. These models are particularly useful for studying cofactor dynamics in native chromatin contexts.
Overexpression
Overexpression of oncoproteins such as MYCN or MYC can be used to study how they interface with the nuclear exosome targeting complex and R-loop biology. Overexpression models help test whether increased oncoprotein levels titrate or redirect exosome activity. They are also useful for identifying synthetic lethal interactions with exosome components.
How EDITGENE Supports nuclear exosome (RNase complex) Research
Researchers studying nuclear exosome (RNase complex)-related genes often need to determine whether a candidate gene is causally involved in RNA surveillance, processing or disease phenotypes. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible interrogation of exosome subunits, cofactors and their regulatory interactions.
Contact EDITGENE today to design your custom CRISPR model for nuclear exosome (RNase complex) research.
Frequently Asked Questions About nuclear exosome (RNase complex)
What is the nuclear exosome (RNase complex)?
The nuclear exosome (RNase complex), GO:0000176, is a multisubunit ribonuclease complex with 3-prime to 5-prime exoribonuclease and endoribonuclease activity that processes and degrades single-stranded RNAs in the nucleus, preventing nuclear export and translation of aberrant RNAs.
What genes are involved in the nuclear exosome (RNase complex)?
Core subunits include EXOSC1-EXOSC9, with EXOSC10 and DIS3 providing catalytic activity; cofactors include ZCCHC8, RBM7 and MTREX in the NEXT complex, as well as TRAMP-like complexes.
What does GO:0000176 mean?
GO:0000176 is the Gene Ontology cellular component term for the nuclear exosome (RNase complex), describing its localization, subunit composition and role in nuclear RNA processing and degradation.
How does the nuclear exosome select its RNA substrates?
Substrate selection is mediated by cofactors such as the NEXT complex, which recognizes short, unstructured RNAs and guides them to the exosome catalytic core; structured 3-prime ends may require unwinding by MTREX.
What diseases are linked to nuclear exosome dysfunction?
Nuclear exosome components and cofactors have been linked to cancer, hematopoietic stem cell failure, R-loop accumulation, genomic instability and RNA processing disorders.
How is the nuclear exosome regulated?
It is regulated by cofactor availability, including NEXT and TRAMP-like complexes, by the helicase MTREX, and by oncoproteins such as MYCN that act as RNA-binding accessory factors.
What methods are used to study the nuclear exosome?
Common methods include RNA-seq, Ribo-seq, structural biology, biochemical nuclease assays, affinity proteomics, R-loop detection and CRISPR knockout screens.
Can CRISPR be used to study nuclear exosome function?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models are widely used to dissect exosome subunit and cofactor functions in RNA surveillance and disease.
What is the NEXT complex?
The NEXT complex is a nuclear exosome targeting complex composed of ZCCHC8, RBM7 and MTREX that delivers short, unstructured RNAs to the exosome for degradation or processing.
Why is the nuclear exosome important for genome stability?
It resolves R-loops and degrades aberrant RNAs, preventing RNA-DNA hybrid accumulation and DNA damage; loss of NEXT components leads to R-loop accumulation and genomic instability.
Conclusion
The nuclear exosome (RNase complex), GO:0000176, is a central RNA surveillance and processing machine that protects the nuclear transcriptome and supports genome stability. Its catalytic subunits EXOSC10 and DIS3, together with cofactors such as the NEXT complex, determine which RNAs are degraded or trimmed. Dysregulation of this system is linked to cancer, stem cell failure and R-loop-associated genomic instability, making it a compelling target for functional genomics. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with RNA-seq, proteomics and imaging, provide a robust toolkit for dissecting nuclear exosome biology and its disease relevance.
References
- 1. Papadopoulos D et al.. 2024. The MYCN oncoprotein is an RNA-binding accessory factor of the nuclear exosome targeting complex.. Mol Cell 84(11):2070-2086.e20 PMID: 38703770
- 2. Uhl L et al.. 2026. MYC binding to nascent RNA suppresses innate immune signaling by R-loop-derived RNA-DNA hybrids.. Cell 189(5):1371-1388.e29 PMID: 41576951
- 3. Abbas DK et al.. 2026. Evolutionarily conserved spliceosome-exosome pathway in nuclear mRNA surveillance.. Genes Dev 40(13-14):1119-1132 PMID: 42140674
- 4. Puno MR et al.. 2022. Structural basis for RNA surveillance by the human nuclear exosome targeting (NEXT) complex.. Cell 185(12):2132-2147.e26 PMID: 35688134
- 5. Schmid M et al.. 2019. The Nuclear RNA Exosome and Its Cofactors.. Adv Exp Med Biol 1203:113-132 PMID: 31811632
- 6. Gerlach P et al.. 2022. Structure and regulation of the nuclear exosome targeting complex guides RNA substrates to the exosome.. Mol Cell 82(13):2505-2518.e7 PMID: 35688157
- 7. Pan Y et al.. 2025. Nuclear exosome targeting complex safeguards hematopoietic stem cell self-renewal and genomic integrity through resolving R loops.. Cell Rep 44(12):116650 PMID: 41353749
- 8. Imamura K et al.. 2024. A functional connection between the Microprocessor and a variant NEXT complex.. Mol Cell 84(21):4158-4174.e6 PMID: 39515294
